Extended Study Highlights Blood Pressure Reduction Potential of Orchestra’s BackBeat

Orchestra BioMed’s cardiac neuromodulation therapy device, BackBeat, is turning heads with impressive results from a recently conducted study. The extended crossover study, which followed a Moderato II evaluation last year that saw the device significantly reduce hypertension in its original randomized participant group...